Group 2 patients were treated with a higher proportion of aggressive extended radical operations, such as combined resections of the diaphragm and lymph node dissections as far as the paraaortic lymph nodes (N4). The resectability rate was 76% in Group 1 and 93% in Group 2, due to the more aggressive operations.
Summary : From 1978 to 1989, a total of 1272 patients with gastric cancer were admitted to Kurume University Hospital. Of these, 1184 (93%) underwent gastric resections.
Of the resected cancers, 140 cases were gastric cancers invading the esophagus, as confirmed by postoperative pathological studies. For all 168 gastric cancers invading the esophagus, the resectability rate was 83% (140/168). These cancers were subdivided chronologically, with those during 1978-1983 included in Group 1 and those during [1984] [1985] [1986] [1987] [1988] [1989] in Group 2 . Group 2 patients were treated with a higher proportion of aggressive extended radical operations, such as combined resections of the diaphragm and lymph node dissections as far as the paraaortic lymph nodes (N4). The resectability rate was 76% in Group 1 and 93% in Group 2, due to the more aggressive operations.
A lower esophagectomy with a total gastrectomy, mainly from a left thoracoabdominal approach, was performed for 71% of the patients in Group 1, and for 90% in Group 2. Lymph node metastasis was related to the extent of esophageal invasion and inversely related to the 5 year-survival rate. In all cases of esophgeal invasion of less than 1 cm, there were no mediastinal lymph node metastases, and the 5 year-survival rate was 76%. On the other hand, when esophageal invasion was more than 4cm, 50% had mediastinal lymph node metastases and the 5 year-survival rate was zero. The tumor size was also related to lymph node metastasis.
When the maximal tumor length was less than 5cm, a negative lymph node metastasis was found in 78% of cases, and the 5 year-survival rate was 76%. On the other hand, when the tumor length was more than 10 cm, only 6% had a negative lymph node metastasis and the 5 year-survival rate was only 15%. 
Results
In cases with esophageal invasion of 0-1cm, lymph node metastasis rate, including both mediastinal and abdominal nodes, was 50%. On the other hand, when esophageal invasion was more than 4 cm, the lymph node metastasis rate was 100%, while the metastasis rate in group 1 regional lymph nodes (ni) was only 7% pathologically (Table 3) . With esophgageal invasion of less than 1 cm, there was no GASTRIC   CANCER  INVADING  THE ESOPHAGUS   313 mediastinal lymph node metastasis, and the 5 year-survival rate was 67%. On the other hand, when esophageal invasion was more than 4cm, 50% had a mediastinal lymph node metastasis, and the 5 year-survival rate was zero (Table 4 ). In cases with maximal tumor length of less than 5cm, a negative lymph node metastasis was found in 78% of the patients, and the 5 year-survival rate was 76%. On the other hand, in cases with maximal tumor length of more than 10 cm, only 6% had a negative lymph node metastasis and the 5 year-survival rate was only 15% (Table 5 ). Anastomotic Other postoperative complications are summarized in Table 6 . The operative mortality rate was 7% for Group 1 and 4% for Group 2 (Table 6) .
The 5 year-survival rates, according to the cancer stage, are showed in Fig. 1 . The overall 5 year-survival rates after curative resections were 45% for Group 1, and 71% for Group 2. At stage III, it was 12% for Group 1, and 46% for Group 2 (p<0.05), due to more aggressive operation for patients in Group 2 (Table 7) . Prognosis of esophageal invasion 5 year-survival rate
Discussion
The prognosis for gastric cancer has improved year by year due to the earlier detection of the cancer and recent advancements in various techniques for treatment.
However, gastric cancer still remains the reading cause of cancer death in Japan. A recent detection rate of early gastric cancer has been reached to about 50% (Nagata et al. 1983 ). However, upper gastric cancer, including cardia cancer, the rate for early gastric cancer was 12% in our recent study (Tanaka et al. 1990) There have been some studies on the prognostic significance of the primary tumor resection, in which the tumor was removed to prevent all the complications of obstruction, bleeding and invasion, enabling the patient to eat normally. This improves the survival time even when performed palliatively (Moreaux et al. 1988) . Clinically, before the operation, direct tumor infiltration into adjacent organs, regional and juxta lymph node enlargement, the presence of ascites, liver metastasis (H-factor) and peritoneal dissemination (P-factor) should be determined using CT, MRI and US. When H (+) and/or P (+) is confirmed, pallative operation is generally indicated. The resectability is ill-defined, but the tumor is considered to be unresectable only when it cannot technically be removed with safety; that is, there is infiltration of the great vessels. However, there have been only few cases involving infiltration to the great vessels. Ellis et al. (1983) reported that operability and resectability rates have generally improved in recent years. These improvements are obviously due to a number of factors.
Patients are coming to surgeons sooner. Surgeon have become more aggressive in operating on and resecting lesions for palliation and cure, because the risk of surgery has declined markedly due to better preoperative preparation and postoperative care, particularly with regard to the use of hyperalimentation and intensive respiratory therapy in selected patients both before and after the operation.
Intravinous hyperalimentation, physicotherapy and cessation of smoking were used preoperatively to optimize respiratory function,
